MoneyWorks4Me

Kopran - Quaterly Results

29 Jul 2025 Evaluate
With no major difference for the quarter endedJune 2025 , the total revenue stood at Rs. 513.35  millions.Net profit declined -17.15% to Rs. 35.18 millions from Rs. 42.46 millions.A decline of 68.68 millions was observed in the OP in the quarter ended June 2025 from 74.01 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 513.35 496.07 3.48 513.35 496.07 3.48 2710.10 3374.56 -19.69
Other Income 17.98 21.20 -15.19 17.98 21.20 -15.19 59.04 167.11 -64.67
PBIDT 68.68 74.01 -7.20 68.68 74.01 -7.20 445.60 536.37 -16.92
Interest 10.42 6.92 50.58 10.42 6.92 50.58 37.66 45.01 -16.33
PBDT 58.26 67.09 -13.16 58.26 67.09 -13.16 407.94 491.36 -16.98
Depreciation 12.19 11.97 1.84 12.19 11.97 1.84 49.99 46.20 8.20
PBT 46.07 55.12 -16.42 46.07 55.12 -16.42 357.95 445.16 -19.59
TAX 10.89 12.66 -13.98 10.89 12.66 -13.98 89.38 98.79 -9.53
Deferred Tax 0.09 -1.33 -106.77 0.09 -1.33 -106.77 3.06 -2.03 -250.74
PAT 35.18 42.46 -17.15 35.18 42.46 -17.15 268.57 346.37 -22.46
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.86 482.11 0.16
PBIDTM(%) 13.38 14.92 -10.33 13.38 14.92 -10.33 16.44 15.89 3.45
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..